WallStreetZenWallStreetZen

NASDAQ: CMMB
Chemomab Therapeutics Ltd Stock Ownership - Who owns Chemomab Therapeutics?

Insider buying vs selling

Have Chemomab Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CMMB insiders and whales buy or sell their stock.

CMMB Shareholders

What type of owners hold Chemomab Therapeutics Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Access Industries Holdings LLC2.43%6,911,166$4.08MInsider
Gabriel Capital Management Ltd1.77%5,034,150$2.97MInsider
Orbimed Israel GP Ltd0.79%2,241,274$1.32MInsider
Orbimed Advisors LLC0.79%2,241,274$1.32MInstitution
George Adi Mor0.47%1,339,964$790.58kInsider
Peter Thiel0.31%877,973$518.00kInsider
Dennison T. Veru0.14%396,540$233.96kInsider
Ikarian Capital LLC0.08%213,392$125.90kInstitution
Morgan Stanley0.02%70,915$41.84kInstitution
Two Sigma Investments LP0.02%56,305$33.22kInstitution

1 of 3

CMMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CMMB0.99%5.96%
MBRX45.78%54.22%Net Buying
BCDA1.04%98.96%Net BuyingNet Buying
GRTX23.78%57.19%Net SellingNet Selling
ELAB0.15%99.85%

Chemomab Therapeutics Stock Ownership FAQ

Who owns Chemomab Therapeutics?

Chemomab Therapeutics (NASDAQ: CMMB) is owned by 0.99% institutional shareholders, 5.96% Chemomab Therapeutics insiders, and 93.05% retail investors. Access Industries Holdings LLC is the largest individual Chemomab Therapeutics shareholder, owning 6.91M shares representing 2.43% of the company. Access Industries Holdings LLC's Chemomab Therapeutics shares are currently valued at $4.84M.

If you're new to stock investing, here's how to buy Chemomab Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.